Different types of intranasal steroids for chronic rhinosinusitisSign up for the PharmacyTimes Newsletter. Clinical Resources Acute Coronary Syndrome. This article was sponsored by Chattem, Inc. These symptoms may occur in response to indoor allergens or outdoor allergens, or both. Intermittent AR is characterized by the presence of calastreme estanozolol for fewer than 4 days in 1 week or for fewer than 4 weeks in 1 year, whereas persistent AR is characterized by the presence of symptoms for more than 4 days in 1 nasal corticosteroid sprays comparison and for more than 4 weeks in 1 year.
Intranasal Corticosteroids: Understanding OTC Options
Sign up for the PharmacyTimes Newsletter. Clinical Resources Acute Coronary Syndrome. This article was sponsored by Chattem, Inc. These symptoms may occur in response to indoor allergens or outdoor allergens, or both. Intermittent AR is characterized by the presence of symptoms for fewer than 4 days in 1 week or for fewer than 4 weeks in 1 year, whereas persistent AR is characterized by the presence of symptoms for more than 4 days in 1 week and for more than 4 weeks in 1 year.
When used appropriately at recommended doses, INSs are generally not associated with substantial systemic adverse effects AEs 1 ; however, local AEs, such as nasal irritation and bleeding, may occur. The incidence of AEs may be minimized by spraying the medication away from the nasal septum. The FDA approved the switches of Nasacort and Flonase from being available only by prescription to being obtainable over the counter on October 11, , and on July 23, , respectively.
When considering treatment options for any condition, however, general factors to take into consideration include efficacy, safety, and product characteristics, such as formulation. In a study of preference in patients 18 years and older with a minimum 2-year history of AR, patients were randomized to rate several characteristics of 3 INS regimens on a point scale.
These regimens included triamcinolone acetonide mcg daily, fluticasone propionate mcg daily, and mometasone furoate mcg daily. Considering these factors together, patients overall preferred the triamcinolone acetonide formulation compared with the others Figure.
After 3 weeks of treatment, patients reported significantly fewer odor-related complaints As the efficacy and safety profiles of INSs are similar, 1 it is important to consider patient preference and the specific characteristics of formulations when selecting an OTC INS. One formulation characteristic that may be important to patients is the presence of alcohol in the liquid vehicle.
Many formulations of INSs contain alcohol, which may contribute to a feeling of dryness after administration. A variety of treatment options for AR are available over the counter.
Having this knowledge, pharmacists can engage in a discussion with individual patients to determine what is important to them in terms of formulation characteristics and provide guidance in selecting an INS. It is also important to consider product cost when helping patients select treatment. For instance, INSs work best when used daily and may not provide maximum relief until they have been used consistently for several days. Severe Weather and Asthma: Pharmacy Week in Review: Personalize the information you receive by selecting targeted content and special offers.
Features and specialized departments cover medication errors, drug interactions, patient education, pharmacy technology, disease state management, patient counseling, product news, pharmacy law and health-system pharmacy.